+634.5%
MRNA vs VEU
+123.6%
+510.9%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | VEU | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | -1.3% | +2.0% | +1.8% |
| 7D | -8.2% | -1.9% | -6.3% | -6.7% |
| 30D | +125.6% | -0.7% | +126.3% | +128.0% |
| 3M | +197.1% | +4.9% | +192.2% | +187.7% |
| 6M | +148.5% | +9.8% | +138.6% | +132.3% |
| YTD | +363.3% | +15.3% | +348.0% | +318.4% |
| 1Y | +462.0% | +23.0% | +439.0% | +385.0% |
| 3Y | +26.9% | +73.5% | -46.6% | -10.7% |
| 5Y | -69.6% | +54.5% | -124.1% | -78.3% |
| All | +634.5% | +123.6% | +510.9% | +372.7% |
Cumulative growth
Daily Returns
Daily percentage return beside VEU.
Daily Out/Under-Performance
Portfolio return minus VEU return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VEU return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded VEU wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling